|
|
|
Patent Medicine
|
Business New Haven
10/19/1998
By: Kristine Hansen
|
NEW HAVEN - Vion Pharmaceuticals Inc. (NASDAQ: VION) has been issued notices of allowance and patents by the U.S. Patent & Trade Office for applications involving two of its candidates for product: the prodrug formulations of Triapine and B-L-FD4C.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|